<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03647332</url>
  </required_header>
  <id_info>
    <org_study_id>2018Stolzenberg</org_study_id>
    <nct_id>NCT03647332</nct_id>
  </id_info>
  <brief_title>Use of Cooled Radiofrequency for the Treatment of Hip Pain Associated With OA of the Hip Compared to Intra-articular Steroid Injections</brief_title>
  <official_title>Use of Cooled Radiofrequency for the Treatment of Hip Pain Associated With OA of the Hip Compared to Intra-articular Steroid Injections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rothman Institute Orthopaedics</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rothman Institute Orthopaedics</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This will be a single-center, prospective, single-blinded randomized clinical trial to&#xD;
      investigate the effectiveness of using cooled RFA for the treatment of OA hip pain and&#xD;
      function in subjects treated with cooled RFA compared with standard of care intra-articular&#xD;
      steroid injections&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">July 5, 2017</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>24 weeks following treatment</time_frame>
    <description>Visual Analog Scale</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">86</enrollment>
  <condition>Osteo Arthritis of Hip</condition>
  <arm_group>
    <arm_group_label>Cooled RFA treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Steroid injection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cooled RFA treatment</intervention_name>
    <description>cooled radiofrequency ablation</description>
    <arm_group_label>Cooled RFA treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Steroid Drug</intervention_name>
    <description>steroid injection</description>
    <arm_group_label>Steroid injection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects presenting with radiographic evidence of hip OA and demonstrating hip pain&#xD;
             for at least 30 days will be targeted. Radiographic evidence of hip OA is defined as&#xD;
             Kellegran-Lawrence grade 2-4&#xD;
&#xD;
          -  Not an operative candidate as per RI joint replacement surgeon OR&#xD;
&#xD;
          -  Subjects who do not desire joint replacement surgery after consultation with RI joint&#xD;
             replacement surgeon&#xD;
&#xD;
          -  Male or non-pregnant female older than 18 years of age&#xD;
&#xD;
          -  willing and able to sign the IRB-approved informed consent document.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any steroid injection in hip within 90 days&#xD;
&#xD;
          -  Local infection at injection site or active systemic infection&#xD;
&#xD;
          -  Anticoagulation status with inability to discontinue medication for appropriate&#xD;
             duration for nerve blocks and RFA given proximity to major artery. (No anticoagulation&#xD;
             contraindications for joint injection)&#xD;
&#xD;
          -  AICD with inability to utilize magnet for RFA per treating cardiologist&#xD;
&#xD;
          -  Body habitus does not allow for placement of longest needles and electrodes&#xD;
             (approximately 15cm) to successfully administer treatment&#xD;
&#xD;
          -  Allergy or severe renal impairment precluding iodionated contrast or magnavist&#xD;
             injection despite standard premedication protocol&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rothman Institute</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tiffany Morrison</last_name>
      <phone>267-339-7818</phone>
      <email>tiffany.morrison@rothmaninstitute.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>August 23, 2018</study_first_submitted>
  <study_first_submitted_qc>August 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 27, 2018</study_first_posted>
  <last_update_submitted>August 23, 2018</last_update_submitted>
  <last_update_submitted_qc>August 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Hip</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

